Astrana HealthSTU:3AM +1.03%87 EV-to-FCF is 17.01 as of Jun. 30, 2026, which is 36% below its 10-year median of 26.48. GuruFocus rates STU:3AM with a GF Score™ of 87/100 and a GF Value™ of €72.06 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 407 Healthcare Providers & Services companies, Astrana Health ranks better than 52.09% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Astrana Health's Enterprise Value is €2,283 Mil.
Astrana Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €134 Mil. Therefore, Astrana Health's EV-to-FCF for today is 17.01.
The historical rank and industry rank for Astrana Health's EV-to-FCF or its related term are showing as below:
STU:3AM'
s EV-to-FCF Range Over the Past 10 Years
Min: -96.15 Med: 26.48 Max: 348.31
Current: 16.75
During the past 13 years, the highest EV-to-FCF of Astrana Health was 348.31. The lowest was -96.15. And the median was 26.48.
STU:3AM's EV-to-FCF is ranked better than 52.09% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 17.51
vs STU:3AM: 16.75
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Astrana Health's PE Ratio (TTM) for today is calculated as:
Astrana Health's share price for today is €40.60.
Astrana Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.527.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Astrana Health EV-to-FCF Related Terms
Astrana Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Astrana Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Astrana Health's EV-to-FCF falls into.
Astrana Health's current Enterprise Value is €2,283 Mil.
Astrana Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €134 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health (STU:3AM) has a EV-to-FCF of 17.01 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Astrana Health and its competitors. This is 36% below median its historical median of 26.48. According to the industry distribution chart, Astrana Health ranks #195 out of 407 companies in the Healthcare Providers & Services industry, placing it in the top 47.9%.
Is Astrana Health's EV-to-FCF too high?
Astrana Health's current EV-to-FCF of 17.01 is 36% below median its 10-year median of 26.48. The Healthcare Providers & Services industry median EV-to-FCF is 17.51. Astrana Health's value of 17.01 is 2.9% below this industry median. Based on the distribution chart, Astrana Health ranks #195 out of 407 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's EV-to-FCF compare to SGRY and SEM?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #195 out of 407 companies for EV-to-FCF. This puts Astrana Health in the upper half of its industry. The industry median EV-to-FCF is 17.51. Astrana Health's value of 17.01 is 2.9% below this benchmark. While the company's 10-year median is 26.48 vs. the industry median of 17.51, Astrana Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.51, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current EV-to-FCF of 17.01 is 2.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current EV-to-FCF is 17.01, which is 36% below median its own 10-year median of 26.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (STU:3AM) is currently considered Significantly Undervalued. The stock's GF Value™ is €72.06, compared to a current price of €40.60 — trading 43.7% below its estimated fair value. The current EV-to-FCF is 17.01, which is 36% below median its 10-year median of 26.48 and 2.9% below the Healthcare Providers & Services industry median of 17.51. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Astrana Health (STU:3AM), the current EV-to-FCF is 17.01 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (STU:3AM) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of €40.60 is trading 43.7% below its estimated GF Value™ of €72.06.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for STU:3AM:
EV-to-FCF: 17.01 (36% below median its 10-year median of 26.48)
GF Value™: €72.06 vs. price of €40.60 (43.7% below fair value)
Industry Position: 2.9% below the Healthcare Providers & Services median (#195 of 407)
No single metric tells the full story. See the STU:3AM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for STU:3AM
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:3AM has been successfully added to your 
